Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Anti... ( Additions to the Human Prote...)

Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM)

Date:6/23/2009

Additions to the Human Protein Atlas, available exclusively through Sigma-Aldrich, bring the portfolio to over 6,100 antibodies powered by Atlas Antibodies

ST. LOUIS, June 23 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) today announced the release of over 2,300 antibody additions to its Prestige Antibodies(R) powered by Atlas Antibodies product line (www.sigma.com/prestige), bringing the total number of highly validated antibodies to over 6,100. Developed by the Human Proteome Resource, these antibodies are available to customers immediately through an exclusive partnership between Sigma-Aldrich and Atlas Antibodies. Prestige Antibodies can provide significant time and cost savings for researchers because they are optimized on a single protocol, resulting in efficient and effective applications.

This addition to the Prestige Antibodies product line is a step toward the Human Proteome Resource's goal to develop at least one antibody to all 22,000 non-redundant human proteins by 2015.

"With this latest addition to the Prestige Antibodies line, Sigma-Aldrich has significantly expanded our antibody offerings, the latest step in our long-term plan to lead the industry in high-quality antibody content," said Dr. David Smoller, President of Sigma-Aldrich's Research Biotech Business Unit. "Our highly validated Prestige Antibodies are ideal for a number of applications, and with our unique online tools we help scientists figure out how to best incorporate them into prospective experiments."

Prestige Antibodies are supported by the publicly available data of the Human Protein Atlas (HPA), part of HUPO's Human Antibody Initiative. Multiple quality assurance testing steps ensure that Prestige Antibodies are highly sp
'/>"/>

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Sigma-Aldrich Introduces New Services Network Complementing Its Life Sciences Product Portfolio
2. Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
3. Sigma-Aldrich Introduces Precisio(TM) Kinases for High-Throughput Screening and Kinase Profiling
4. Sigma-Aldrich to Present at the Baird 2009 Growth Stock Conference on Tuesday, May 12, 2009
5. Sigma-Aldrich to Present at the Bank of America and Merrill Lynch 2009 Healthcare Conference on Wednesday, May 13, 2009
6. Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening
7. Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform
8. Sigma-Aldrich Acquires Sigal Ltda and Expands Operations in Chile
9. Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal
10. Sigma-Aldrich Introduces MISSION(R) LentiPlex(TM) Pooled shRNA Libraries to Enable Rapid Whole Genome Screening in Primary Cells, Stem Cells or Tumor Cells
11. Sigma-Aldrich (NASDAQ:SIAL) Announces it Has Filed Its December 31, 2008 Form 10-K

Post Your Comments:

Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Anti...( Additions to the Human Prote...)